Phase 1 Melanoma Metastatic Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Melanoma MetastaticMucosal MelanomaUveal Melanoma, Metastatic

Alpha-9 Oncology USA Inc.50 enrolled4 locationsNCT07076550

Recruiting

Phase 1

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

SarcomaAdvanced MelanomaMelanoma Metastatic

Centre Hospitalier Universitaire Vaudois9 enrolled2 locationsNCT06889766

Recruiting

Phase 1

T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Melanoma Metastatic

Inge Marie Svane10 enrolled1 locationNCT06783270